Old Web
English
Sign In
Acemap
>
authorDetail
>
Erik Alcantar-Orozco
Erik Alcantar-Orozco
Medicine
NKG2D
Oncology
Internal medicine
Refractory
6
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
407 A phase 1b KEYNOTE-B79 trial evaluating non-gene edited allogeneic CAR T-cells, CYAD-101, post FOLFOX preconditioning, followed by pembrolizumab, in refractory metastatic colorectal cancer patients
2021
Journal for ImmunoTherapy of Cancer
Anne Flament
Frederic Lehmann
Erik Alcantar-Orozco
Emilie Cerf
Caroline Lonez
David E. Gilham
Charles Morris
Show All
Source
Cite
Save
Citations (0)
Immunicy-1: Targeting BCMA with Cyad-211 to Establish Proof of Concept of an shRNA-Based Allogeneic CAR T Cell Therapy Platform
2021
Blood
Ahmad-Samer Al-Homsi
Sébastien Anguille
Dries Deeren
Taiga Nishihori
Nathalie Meuleman
Maher Abdul-Hay
Gareth J. Morgan
Jason Brayer
Nathalie Braun
Caroline Lonez
Marie-Sophie Dheur
Erik Alcantar-Orozco
David E. Gilham
Anne Flament
Frederic Lehmann
Show All
Source
Cite
Save
Citations (0)
1